[{"Assets_0_Q3_USD":614170000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":21885000.0,"NetIncomeLoss_1_Q3_USD":11483000.0,"NetIncomeLoss_3_Q3_USD":38769000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":34840370.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":34681846.0,"StockholdersEquity_0_Q3_USD":467332000.0,"EarningsPerShareBasic_1_Q3_USD":0.33,"EarningsPerShareBasic_3_Q3_USD":1.12,"Ticker":"PEN","CIK":"1321732","name":"PENUMBRA INC","OfficialName":"Penumbra Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"7821675869.0","Country":"nan","Sector":"Health Care","Industry":"Medical\/Dental Instruments","Market":"NYSE","SP500":"nan","filed":"20191107"}]